Financials

  • Market Capitalization 152.07 M
  • Employee 152
  • Founded 2013
  • CEO N/A
  • Website www.lenz-tx.com
  • Headquarter Delaware, United States
  • FIGI BBG00XDH4NZ2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.61
Rapporto prezzo/fatturato
24.15

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3743
NRXP
NRX Pharmaceuticals, Inc. - Common Stock
3.55 USD-1.93%+0.85%+2.01%+99.44%153.70 M USD
3744
INDP
Indaptus Therapeutics, Inc. - Common Stock
1.15 USD-0.86%-10.16%-34.66%-39.47%153.23 M USD
3752
EQ
Equillium, Inc. - Common Stock
2.40 USD-2.04%+3.90%+5.73%+33.33%152.18 M USD
3756
UNCY
Unicycive Therapeutics, Inc. - Common Stock
5.37 USD-2.36%-3.07%+7.83%-17.51%149.58 M USD